COVID-19 | November 22 Second wave news: COVID-19 cases, measures and restrictions
The global coronavirus pandemic exceeds 1.3 million deaths worldwide, according to the Johns Hopkins University baseline count. The number of infected amounts to more than 53.7 million.
The Ministry of Health reported this Friday that COVID-19 has already left 42,619 dead and that there are 1,556,730 cases diagnosed in Spain since the start of the coronavirus pandemic.
The measures taken on the continent are beginning to show encouraging results. Thus, in France they celebrate the decline in the number of new cases, deaths and admissions to intensive care. For its part, the United Kingdom will not extend the four-week confinement when it ends on December 2. “Recent positive advances in vaccines and massive testing give hope that the use of the restrictions to combat the virus can be gradually reduced by spring,” the government said in a statement. Italy, for its part, will start an “unprecedented vaccination campaign” at the end of January, according to the Minister of Health, Roberto Speranza. Meanwhile, Portugal tightens restrictions with the closure of schools and public administrations between November 30 and December 7.
Lpez Obrador, president of Mexico, asked the G20 countries not to take drastic measures to prevent the spread of the coronavirus. “[Hay que] abandon the temptation to impose authoritarian measures such as excessive confinement or a curfew. Nothing by force, everything by conviction and reason, “he stated to reaffirm his idea that confinement should not be mandatory. Despite the fact that the country exceeds 100,000 dead and is only surpassed by the United States and Brazil in America, the measures of the Mexican government are not as strict as in Europe.
The US Food and Drug Administration (FDA) has given the green light to the use of Regeneron, the drug popularized after Donald Trump took it when he was infected with the coronavirus. The treatment is based on a cocktail of antibodies and studies have shown that its early application improves the condition of patients. This granted emergency authorization will allow
to patients over 12 years of age who have the possibility of developing serious symptoms and who are neither hospitalized nor need oxygen, as The New York Times has pointed out. The former president had promised to guarantee free access to this drug as soon as he recovered from the disease and now the federal government has invested some 421.7 million euros so that the first 300,000 doses reach the population free of charge, although they can also be bought by those with health insurance. In addition, the company, after reaching an agreement with the Swiss company Roche, estimates that by the end of January it could already have supplied some 500,000 people, including the 80,000 who will already enjoy the drug by the end of this month.